JP5980318B2 - 新規のフタラジノン−ピロロピリミジンカルボキサミド誘導体 - Google Patents

新規のフタラジノン−ピロロピリミジンカルボキサミド誘導体 Download PDF

Info

Publication number
JP5980318B2
JP5980318B2 JP2014515155A JP2014515155A JP5980318B2 JP 5980318 B2 JP5980318 B2 JP 5980318B2 JP 2014515155 A JP2014515155 A JP 2014515155A JP 2014515155 A JP2014515155 A JP 2014515155A JP 5980318 B2 JP5980318 B2 JP 5980318B2
Authority
JP
Japan
Prior art keywords
oxo
dimethoxyphenyl
piperidin
pyrrolo
cyclopropylmethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2014515155A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014517021A (ja
JP2014517021A5 (https=
Inventor
シュテンゲル トーマス
シュテンゲル トーマス
トーマス　マイアー
マイアー トーマス
マン アレクサンダー
マン アレクサンダー
シュタードルヴィーザー ヨーゼフ
シュタードルヴィーザー ヨーゼフ
ディーター　フロッカーツィ
フロッカーツィ ディーター
パール アンドレアス
パール アンドレアス
ベネディクトゥス エーヴァルト
ベネディクトゥス エーヴァルト
ヘスマン マヌエラ
ヘスマン マヌエラ
カーナッハー トビアス
カーナッハー トビアス
フッソング ラグナ
フッソング ラグナ
ツィット クリストフ
ツィット クリストフ
クリストフ ホルスト ハンス
クリストフ ホルスト ハンス
フメル ロルフ−ペーター
フメル ロルフ−ペーター
フィアテルハウス マーティン
フィアテルハウス マーティン
テノール ヘアマン
テノール ヘアマン
ドゥンカン トアステン
ドゥンカン トアステン
ハッツェルマン アーミン
ハッツェルマン アーミン
ヘスリンガー クリスティアン
ヘスリンガー クリスティアン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Takeda GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44764312&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP5980318(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda GmbH filed Critical Takeda GmbH
Publication of JP2014517021A publication Critical patent/JP2014517021A/ja
Publication of JP2014517021A5 publication Critical patent/JP2014517021A5/ja
Application granted granted Critical
Publication of JP5980318B2 publication Critical patent/JP5980318B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2014515155A 2011-06-17 2012-06-12 新規のフタラジノン−ピロロピリミジンカルボキサミド誘導体 Expired - Fee Related JP5980318B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11170440.9 2011-06-17
EP11170440 2011-06-17
PCT/EP2012/061084 WO2012171900A1 (en) 2011-06-17 2012-06-12 Novel phthalazinone-pyrrolopyrimidinecarboxamide derivatives

Publications (3)

Publication Number Publication Date
JP2014517021A JP2014517021A (ja) 2014-07-17
JP2014517021A5 JP2014517021A5 (https=) 2015-08-06
JP5980318B2 true JP5980318B2 (ja) 2016-08-31

Family

ID=44764312

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014515155A Expired - Fee Related JP5980318B2 (ja) 2011-06-17 2012-06-12 新規のフタラジノン−ピロロピリミジンカルボキサミド誘導体

Country Status (22)

Country Link
US (2) US20140112945A1 (https=)
EP (1) EP2721030B1 (https=)
JP (1) JP5980318B2 (https=)
KR (1) KR20140037195A (https=)
CN (1) CN103582644B (https=)
AR (1) AR086915A1 (https=)
AU (1) AU2012269133A1 (https=)
BR (1) BR112013031791A2 (https=)
CA (1) CA2837248A1 (https=)
CL (1) CL2013003556A1 (https=)
CO (1) CO6852074A2 (https=)
CR (1) CR20130656A (https=)
DO (1) DOP2013000298A (https=)
EA (1) EA023713B1 (https=)
EC (1) ECSP13013076A (https=)
ES (1) ES2564882T3 (https=)
MA (1) MA35269B1 (https=)
MX (1) MX2013014888A (https=)
PE (1) PE20140648A1 (https=)
PH (1) PH12013502546A1 (https=)
TN (1) TN2013000439A1 (https=)
WO (1) WO2012171900A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170133497A (ko) 2015-04-09 2017-12-05 갈데르마 소시에떼아노님 인디고 내추럴리스로부터의 추출물 및 그의 제조 방법
JP6803849B2 (ja) * 2015-04-09 2020-12-23 ガルデルマ・ソシエテ・アノニム インジゴナチュラリス又はインジゴ産生植物の抽出物を用いたアトピー性皮膚炎の処置
BR112017021190B1 (pt) 2015-04-09 2021-12-21 Galderma Sa. Uso de uma composição farmacêutica que compreende um extrato de indigo naturalis
EP3280428A1 (en) 2015-04-09 2018-02-14 Galderma S.A. Antibacterial indigo naturalis or indigo-producing plant extract and use thereof
WO2022006470A1 (en) 2020-07-01 2022-01-06 Vanderbilt University Methods of treatment for a kidney disease

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
ATE111364T1 (de) 1989-05-31 1994-09-15 Fisons Plc Medikament und inhalationsvorrichtung dafür.
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
DE69131867T2 (de) 1990-03-23 2000-05-18 Minnesota Mining And Mfg. Co., Saint Paul Anwendung von löslichen fluorhaltigen Tensiden zur Herstellung von Aerosol-Präparaten mit dosierter Abgabe
ATE114112T1 (de) 1990-10-18 1994-12-15 Minnesota Mining & Mfg Aerosolzubereitung, die beclometason 17,21- dipropionat enthält.
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
GB9213874D0 (en) 1992-06-30 1992-08-12 Fisons Plc Process to novel medicament form
GB9306703D0 (en) 1993-03-31 1993-05-26 Fisons Plc Inhalation device
IL111194A (en) 1993-10-08 1998-02-08 Fisons Plc Process for the production of medicament formulations
BR9806752A (pt) * 1997-01-15 2000-03-14 Byk Gulden Lomberg Chem Fab Ftalazinonas.
SI1070056T1 (en) * 1998-03-14 2004-12-31 Altana Pharma Ag Phthalazinone pde iii/iv inhibitors
JP4672143B2 (ja) 1998-08-04 2011-04-20 ヤゴテック アーゲー 医薬用エーロゾル製剤
US6397838B1 (en) 1998-12-23 2002-06-04 Battelle Pulmonary Therapeutics, Inc. Pulmonary aerosol delivery device and method
AU777167B2 (en) 1999-04-23 2004-10-07 Battelle Memorial Institute Directionally controlled EHD aerosol sprayer
IL146034A0 (en) 1999-04-23 2002-07-25 Battelle Memorial Institute High mass transfer electrosprayer
NZ522882A (en) * 2000-06-05 2004-07-30 Altana Pharma Bv Pyridazinone compounds effective as beta-2-adrenoreceptor agonists as well as PDE4-inhibitors
ES2260299T3 (es) 2000-10-09 2006-11-01 3M Innovative Properties Company Formulaciones medicinales en aerosol.
CZ20032491A3 (cs) 2001-02-15 2004-01-14 Altana Pharma Ag Ftalazinonpiperidinové deriváty
EP1385848A2 (en) 2001-04-25 2004-02-04 ALTANA Pharma AG Phtalazinones derivatives useful as pde4/7 inhibitors
BR0313330A (pt) 2002-08-10 2005-06-14 Altana Pharma Ag Piperidina-ftalazonas substituìdas com pirrolidinadiona como inibidores de pde4
EP1556369A1 (en) * 2002-08-10 2005-07-27 ALTANA Pharma AG Pyridazinone-derivatives as pde4 inhibitors
WO2004018449A1 (en) 2002-08-10 2004-03-04 Altana Pharma Ag Piperidine-derivatives as pde4 inhibitors
EP1587512A2 (en) * 2003-01-14 2005-10-26 ALTANA Pharma AG Pde4 inhibitors for the treatment of neoplasms of lymphoid cells
WO2005075457A1 (en) * 2004-02-04 2005-08-18 Altana Pharma Ag Phthalazinone-derivatives as pde4 inhibitors
DE602005005638T2 (de) 2004-02-04 2009-05-14 Nycomed Gmbh 2-(piperidin-4-yl)-4,5-dihydro-2h-pyridazin-3-on-derivate als pde4-inhibitoren
AR070454A1 (es) * 2008-02-27 2010-04-07 Nycomed Gmbh Pirrolopirimidincarboxamidas y composiciones farmaceuticas que las comprenden
AR077898A1 (es) * 2009-08-26 2011-09-28 Nycomed Gmbh Metilpirrolopirimidincarboxamidas

Also Published As

Publication number Publication date
AR086915A1 (es) 2014-01-29
CR20130656A (es) 2014-02-18
EP2721030B1 (en) 2015-12-16
TN2013000439A1 (en) 2015-03-30
CO6852074A2 (es) 2014-01-30
CA2837248A1 (en) 2012-12-20
JP2014517021A (ja) 2014-07-17
CN103582644B (zh) 2016-07-20
MX2013014888A (es) 2014-02-27
CN103582644A (zh) 2014-02-12
KR20140037195A (ko) 2014-03-26
WO2012171900A1 (en) 2012-12-20
US20140112945A1 (en) 2014-04-24
EA201400001A1 (ru) 2014-05-30
ECSP13013076A (es) 2014-01-31
US20160108049A1 (en) 2016-04-21
MA35269B1 (fr) 2014-07-03
CL2013003556A1 (es) 2014-06-13
ES2564882T3 (es) 2016-03-29
PH12013502546A1 (en) 2014-01-27
AU2012269133A1 (en) 2014-01-30
BR112013031791A2 (pt) 2017-01-31
EA023713B1 (ru) 2016-07-29
EP2721030A1 (en) 2014-04-23
PE20140648A1 (es) 2014-05-30
DOP2013000298A (es) 2014-03-31

Similar Documents

Publication Publication Date Title
CN103857288B (zh) 作为激酶抑制剂的氨基-喹啉
TWI468411B (zh) 新穎３，４，４ａ，１０ｂ－四氫－１Ｈ－噻喃并［４，３－ｃ］異喹啉化合物
WO2019224773A1 (en) Heterocyclic amides as rip1 kinase inhibitors
JP5980318B2 (ja) 新規のフタラジノン−ピロロピリミジンカルボキサミド誘導体
JP2014517021A5 (https=)
US12606562B2 (en) Pyridopyrimidines derivatives as P2X3 inhibitors
KR20250081951A (ko) 금속 채널 활성화제를 포함하는 병용 요법
KR20170003667A (ko) 카르복스아미드 유도체
EP2721036B1 (en) Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c]isoquinoline compounds
TW201305174A (zh) 新穎呔嗪酮－吡咯并嘧啶甲醯胺衍生物
WO2019154329A1 (zh) 具有bet抑制活性的化合物及其制备方法和用途
HK1192555A (en) Novel phthalazinone-pyrrolopyrimidinecarboxamide derivatives
TW202241428A (zh) Ｓａｒｓ－ｃｏｖ－２所引起之病毒感染的方法及治療
HK1174326B (en) 3,4,4a,10b-tetrahydr-1h-thiopyrano-[4, 3-c] isoquinoline derivatives

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A712

Effective date: 20150414

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150611

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150611

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20150617

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160125

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160128

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160422

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160627

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160726

R150 Certificate of patent or registration of utility model

Ref document number: 5980318

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees